Roche escapes lawsuit claiming it illegally quashed Biocad's biosimilar hopes

Russian drugmaker Biocad accused Roche of playing dirty in that country to thwart its ambitions in the U.S. Those claims didn't fly in 2017, when a district court dismissed the suit, saying the alleged lawbreaking happened in Russia, not the U.S.—and now, an appeals court has agreed.